Literature DB >> 4916567

The concept of an 'autoallergic' hepatitis.

D Doniach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4916567      PMCID: PMC1811796     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  41 in total

1.  ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY.

Authors:  A E READ; S SHERLOCK; C V HARRISON
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

2.  Complement fixing reactions with liver tissue in human disease.

Authors:  L J PASNICK; G N BEALL; P P VANARSDEL
Journal:  Am J Med       Date:  1962-11       Impact factor: 4.965

3.  Anti-cytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases.

Authors:  H R DEICHER; H R HOLMAN; H G KUNKEL
Journal:  Arthritis Rheum       Date:  1960-02

4.  Serological diagnosis of primary biliary cirrhosis: a potential clue to pathogenesis.

Authors:  F S Kantor; G Klatskin
Journal:  Trans Assoc Am Physicians       Date:  1967

5.  Immunoglobulins in chronic liver disease.

Authors:  T Feizi
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

6.  Bleeding oesophageal varices as the presenting feature in primary bilirary cirrhosis.

Authors:  R Zeegen; A G Stansfeld; A M Dawson; A H Hunt
Journal:  Lancet       Date:  1969-07-05       Impact factor: 79.321

Review 7.  A unified concept of autoimmune hepatitis.

Authors:  D Doniach; J G Walker
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

8.  Antimitochondrial antibodies in jaundice following drug administration.

Authors:  M Rodriguez; F Paronetto; F Schaffner; H Popper
Journal:  JAMA       Date:  1969-04-07       Impact factor: 56.272

9.  Relation of Australia-SH antigen to the willowbrook MS-2 strain.

Authors:  J P Giles; R W McCollum; L W Berndtson; S Krugman
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

10.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

View more
  13 in total

1.  Cell-mediated immune reactivity in liver disease.

Authors:  P A Bacon; H Berry; R Bown
Journal:  Gut       Date:  1972-06       Impact factor: 23.059

2.  Leucocyte migration inhibition in liver disease.

Authors:  C Vergani; T Oldoni; N Dioguardi
Journal:  J Clin Pathol       Date:  1974-10       Impact factor: 3.411

3.  Chronic active hepatitis and Graves' disease.

Authors:  W G Thompson; I R Hart
Journal:  Am J Dig Dis       Date:  1973-02

4.  Viral hepatitis related antigens in 'autoimmune' hepatic disorders.

Authors:  D Doniach; S Del Prete; D S Dane; J H Walsh
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

5.  Scleroderma and portal hypertension.

Authors:  J S Morris; T Htut; A E Read
Journal:  Ann Rheum Dis       Date:  1972-07       Impact factor: 19.103

6.  Cell-mediated immune responses in chronic liver diseases.

Authors:  M G Smith; P L Golding; A L Eddleston; C G Mitchell; A Kemp; R Williams
Journal:  Br Med J       Date:  1972-02-26

7.  Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction.

Authors:  J Webb; K Whaley; R N MacSween; G Nuki; W C Dick; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

Review 8.  The immunologic basis of liver disease.

Authors:  H Popper
Journal:  Bull N Y Acad Med       Date:  1975-04

9.  Cell-mediated immune response in primary biliary cirrhosis to a protein fraction from human bile.

Authors:  A L Eddleston; I G McFarlane; C G Mitchell; W D Reed; R Williams
Journal:  Br Med J       Date:  1973-11-03

10.  Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release.

Authors:  E Fernandez-Cruz; P Escartin; A Bootello; M Kreisler; J M Segovia de Arana
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.